216 related articles for article (PubMed ID: 17962192)
1. Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP.
Nie L; Wu H; Sun XH
J Biol Chem; 2008 Jan; 283(2):684-92. PubMed ID: 17962192
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation.
Terme JM; Lhermitte L; Asnafi V; Jalinot P
Blood; 2009 Jun; 113(26):6695-8. PubMed ID: 19406989
[TBL] [Abstract][Full Text] [Related]
3. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
Huang Z; Nie L; Xu M; Sun XH
Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
5. The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors.
Dey S; Curtis DJ; Jane SM; Brandt SJ
Mol Cell Biol; 2010 May; 30(9):2181-92. PubMed ID: 20194619
[TBL] [Abstract][Full Text] [Related]
6. The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase.
Tokarz S; Berset C; La Rue J; Friedman K; Nakayama K; Nakayama K; Zhang DE; Lanker S
J Biol Chem; 2004 Nov; 279(45):46424-30. PubMed ID: 15342634
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells.
Tang T; Arbiser JL; Brandt SJ
J Biol Chem; 2002 May; 277(21):18365-72. PubMed ID: 11904294
[TBL] [Abstract][Full Text] [Related]
8. Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.
Nie L; Zhao Y; Wu W; Yang YZ; Wang HC; Sun XH
Cell Res; 2011 May; 21(5):754-69. PubMed ID: 21119685
[TBL] [Abstract][Full Text] [Related]
9. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.
Nie L; Xu M; Vladimirova A; Sun XH
EMBO J; 2003 Nov; 22(21):5780-92. PubMed ID: 14592976
[TBL] [Abstract][Full Text] [Related]
10. A mechanism underlying NOTCH-induced and ubiquitin-mediated JAK3 degradation.
Wu W; Sun XH
J Biol Chem; 2011 Dec; 286(48):41153-41162. PubMed ID: 21969365
[TBL] [Abstract][Full Text] [Related]
11. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
Hsu HL; Wadman I; Tsan JT; Baer R
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
[TBL] [Abstract][Full Text] [Related]
12. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation.
Nielsen AL; Norby PL; Pedersen FS; Jorgensen P
J Biol Chem; 1996 Dec; 271(49):31463-9. PubMed ID: 8940159
[TBL] [Abstract][Full Text] [Related]
13. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
[TBL] [Abstract][Full Text] [Related]
15. Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1.
Lausen J; Pless O; Leonard F; Kuvardina ON; Koch B; Leutz A
J Biol Chem; 2010 Feb; 285(8):5338-46. PubMed ID: 20028976
[TBL] [Abstract][Full Text] [Related]
16. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
17. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.
Talora C; Cialfi S; Oliviero C; Palermo R; Pascucci M; Frati L; Vacca A; Gulino A; Screpanti I
Blood; 2006 Apr; 107(8):3313-20. PubMed ID: 16368887
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.
Kassouf MT; Hughes JR; Taylor S; McGowan SJ; Soneji S; Green AL; Vyas P; Porcher C
Genome Res; 2010 Aug; 20(8):1064-83. PubMed ID: 20566737
[TBL] [Abstract][Full Text] [Related]
19. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages.
Palii CG; Perez-Iratxeta C; Yao Z; Cao Y; Dai F; Davison J; Atkins H; Allan D; Dilworth FJ; Gentleman R; Tapscott SJ; Brand M
EMBO J; 2011 Feb; 30(3):494-509. PubMed ID: 21179004
[TBL] [Abstract][Full Text] [Related]
20. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
